Skip to content

Author: emagine

Press Release

SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services

FOR IMMEDIATE RELEASE RANCHO CORDOVA, CA (December 11, 2024) — SK pharmteco, a global contract development, manufacturing, and analytical testing...

Article

SK pharmteco Published in BioProcess International: Elevating the CGT Manufacturing Game: How Outsourcing Enables Success

SK pharmteco was recently featured in “BioProcess International” in their article titled “Elevating the CGT Manufacturing Game: How Outsourcing Enables...

Article

SK pharmteco Published in Pharma’s Almanac: What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

SK pharmteco recently participated in a roundtable discussion with “Pharma’s Almanac” titled “What are the Current Investment Trends in the...

Article

SK pharmteco Published in Pharma’s Almanac: How Can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

SK pharmteco recently participated in a roundtable discussion with “Pharma’s Almanac” titled “How Can Life Science Technology Providers Support the...

News

SK pharmteco Names Andrew Fenny Chief Commercial Officer

September 27, 2023 FOR IMMEDIATE RELEASE RANCHO CORDOVA, Ca. (September 27, 2023) – SK pharmteco, a global contract development and manufacturing...

Article

How CDMOs Have Become Emerging Technology Influencers

The science behind advanced, cell-and-gene-based drugs is developing rapidly, opening new opportunities for targeted, highly effective therapeutics.

Article

Cell Therapy Manufacturing: Build or Buy?

Allogeneic cell therapy is poised to be paradigm-shifting treatment from a scale, cost, and reach perspective. In this white paper, we discuss the considerations for…

Article

Getting More Gene and Cell Therapy Treatments To Patients

Getting More Gene and Cell Therapy Treatments To Patients